(Q34139766)

English

Her2 and trastuzumab in breast cancer

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

title

Her2 and trastuzumab in breast cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

J Horton

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11176040

retrieved

31 July 2017

publication date

1 January 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

11176040

retrieved

31 July 2017

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11176040

retrieved

31 July 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11176040

retrieved

31 July 2017

page(s)

103-110

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11176040

retrieved

31 July 2017

cites work

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F107327480100800113

retrieved

21 January 2018

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F107327480100800113

retrieved

21 January 2018

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F107327480100800113

retrieved

21 January 2018

HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1177%2F107327480100800113

retrieved

21 January 2018

Identifiers

DOI

10.1177/107327480100800113

0 references

PubMed publication ID

11176040

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11176040

retrieved

31 July 2017

(Q34139766)

Her2 and trastuzumab in breast cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)